Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower cardiovascular events in type 2 diabetes mellitus (T2DM) patients, although the mechanisms underlying these benefits are not clearly understood. Our aim...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Sergio Gamaza-Chuli án, Enrique Díaz-Retamino, Fátima González-Testón, José Carlos Gaitero, María José Castillo, Raquel Alfaro, Elías Rodríguez, Eva González-Caballero and Antonio Martín-Santana Tags: Research article Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | SGLT2 Inhibitors | Sodium | Study